Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nanomolecular targeting of dendritic cells for ovarian cancer therapy.

Literature DB >> 19852731

Nanomolecular targeting of dendritic cells for ovarian cancer therapy.

Juan R Cubillos-Ruiz, Steven Fiering, Jose R Conejo-Garcia.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Antineoplastic Agents

Year: 2009 PMID： 19852731 PMCID： PMC3056055 DOI： 10.2217/fon.09.101

Source DB: PubMed Journal: Future Oncol ISSN： 1479-6694 Impact factor: 3.404

× No keyword cloud information.

20 in total

1. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Authors: Eiichi Sato; Sara H Olson; Jiyoung Ahn; Brian Bundy; Hiroyoshi Nishikawa; Feng Qian; Achim A Jungbluth; Denise Frosina; Sacha Gnjatic; Christine Ambrosone; James Kepner; Tosin Odunsi; Gerd Ritter; Shashikant Lele; Yao-Tseng Chen; Haruo Ohtani; Lloyd J Old; Kunle Odunsi
Journal: Proc Natl Acad Sci U S A Date: 2005-12-12 Impact factor: 11.205

2. Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.

Authors: David Ranney; Peter Antich; Eric Dadey; Ralph Mason; Padmakar Kulkarni; Onkar Singh; Huagang Chen; Anca Constantanescu; Robert Parkey
Journal: J Control Release Date: 2005-11-14 Impact factor: 9.776

3. In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells.

Authors: Uciane K Scarlett; Juan R Cubillos-Ruiz; Yolanda C Nesbeth; Diana G Martinez; Xavier Engle; Andrew T Gewirtz; Cory L Ahonen; Jose R Conejo-Garcia
Journal: Cancer Res Date: 2009-09-08 Impact factor: 12.701

Review 4. Novel therapeutic agents in ovarian cancer.

Authors: R Agarwal; M Linch; S B Kaye
Journal: Eur J Surg Oncol Date: 2006-05-15 Impact factor: 4.424

5. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.

Authors: Jose R Conejo-Garcia; Fabian Benencia; Maria-Cecilia Courreges; Eugene Kang; Alisha Mohamed-Hadley; Ronald J Buckanovich; David O Holtz; Ann Jenkins; Hana Na; Lin Zhang; Daniel S Wagner; Dionyssios Katsaros; Richard Caroll; George Coukos
Journal: Nat Med Date: 2004-08-29 Impact factor: 53.440

6. Cancer statistics, 2008.

Authors: Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal: CA Cancer J Clin Date: 2008-02-20 Impact factor: 508.702

7. Vascular leukocytes contribute to tumor vascularization.

Authors: Jose R Conejo-Garcia; Ronald J Buckanovich; Fabian Benencia; Maria C Courreges; Stephen C Rubin; Richard G Carroll; George Coukos
Journal: Blood Date: 2004-09-09 Impact factor: 22.113

8. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.

Authors: Junzo Hamanishi; Masaki Mandai; Masashi Iwasaki; Taku Okazaki; Yoshimasa Tanaka; Ken Yamaguchi; Toshihiro Higuchi; Haruhiko Yagi; Kenji Takakura; Nagahiro Minato; Tasuku Honjo; Shingo Fujii
Journal: Proc Natl Acad Sci U S A Date: 2007-02-21 Impact factor: 11.205

9. Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.

Authors: S Peter Bak; Julie Jo Walters; Motohiro Takeya; Jose R Conejo-Garcia; Brent L Berwin
Journal: Cancer Res Date: 2007-05-15 Impact factor: 12.701

10. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors: Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal: N Engl J Med Date: 2003-01-16 Impact factor: 91.245

13 in total

Review 1. Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer.

Authors: Juan R Cubillos-Ruiz; Sarah E Bettigole; Laurie H Glimcher
Journal: Cell Date: 2017-02-09 Impact factor: 41.582

2. The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Authors: Leslee Sprague; Maria Muccioli; Michelle Pate; Evan Meles; John McGinty; Harika Nandigam; Amritha K Venkatesh; Ming-Yu Gu; Kristen Mansfield; Andrew Rutowski; Omowaleola Omosebi; Maria C Courreges; Fabian Benencia
Journal: BMC Immunol Date: 2011-06-06 Impact factor: 3.615

3. Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Authors: Jacob Osterbur; Leslee Sprague; Maria Muccioli; Michelle Pate; Kristen Mansfield; John McGinty; Yihan Li; Yandi Li; Venktesh Shirure; Maria Cecilia Courreges; Fabian Benencia
Journal: Immunobiology Date: 2012-02-27 Impact factor: 3.144

4. CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells.

Authors: Juan R Cubillos-Ruiz; Diana Martinez; Uciane K Scarlett; Melanie R Rutkowski; Yolanda C Nesbeth; Ana L Camposeco-Jacobs; Jose R Conejo-Garcia
Journal: Oncotarget Date: 2010-09

Review 5. Molecular Pathways: Immunosuppressive Roles of IRE1α-XBP1 Signaling in Dendritic Cells of the Tumor Microenvironment.

Authors: Juan R Cubillos-Ruiz; Sarah E Bettigole; Laurie H Glimcher
Journal: Clin Cancer Res Date: 2016-03-15 Impact factor: 12.531

6. Evaluation of a nanotechnology-based approach to induce gene-expression in human THP-1 macrophages under inflammatory conditions.

Authors: Laura Bernal; Abigail Alvarado-Vázquez; David Wilson Ferreira; Candler A Paige; Cristina Ulecia-Morón; Bailey Hill; Marina Caesar; E Alfonso Romero-Sandoval
Journal: Immunobiology Date: 2016-09-05 Impact factor: 3.144